Castle | $1,000,000 | (Jun 27, 2025)
Handspring Health | $12,000,000 | (Jun 27, 2025)
DejaBlue | $8,000,000 | (Jun 27, 2025)
Certified by Founder
Lodge
Brightstar Therapeutics
start up
United States
- Lexington, Kentucky
- 21/04/2023
- Series A
- Undisclosed Amount
Brightstar Therapeutics is a biotechnology company focused on providing innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases.
Brightstar Therapeutics is the first company to offer a long-term solution for persistent epithelial defects, and partial limbal stem cell deficiency through its advanced corneal allograft, BrightMEM.
- Industry Hospital & Health Care
- Website https://www.brightstartx.com/
- LinkedIn https://www.linkedin.com/company/brightstar-therapeutics/
Certify | $40,000,000 | (Jun 27, 2025)
Tacta Systems, Inc. | $7,000,000 | (Jun 27, 2025)
Antler Bio | $4,212,546 | (Jun 27, 2025)
Raphe mPhibr | $100,000,000 | (Jun 27, 2025)
DataBahn.ai | $17,000,000 | (Jun 27, 2025)
Klutch AI | $8,000,000 | (Jun 27, 2025)
Niural | $31,000,000 | (Jun 27, 2025)
Jarsy Inc | $5,000,000 | (Jun 27, 2025)
Spekter Games | $5,000,000 | (Jun 27, 2025)